Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 238

1.

Erratum to: Autologous tumor lysate/Bacillus Calmette-Guérin immunotherapy as an adjuvant to conventional breast cancer therapy.

Convit J, Montesinos H, Oviedo H, Romero G, Maccarone B, Essenfeld E, Convit A, Palacios LE.

Clin Transl Oncol. 2016 Jun;18(6):650. No abstract available.

2.

Autologous tumor lysate/Bacillus Calmette-Guérin immunotherapy as an adjuvant to conventional breast cancer therapy.

Convit J, Montesinos H, Oviedo H, Romero G, Maccarone B, Essenfeld E, Convit A, Palacios LE.

Clin Transl Oncol. 2015 Nov;17(11):884-7. doi: 10.1007/s12094-015-1320-0. Epub 2015 Jun 16. Erratum in: Clin Transl Oncol. 2016 Jun;18(6):650.

3.

Intermediate cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis successfully treated with fluconazole.

Daly K, De Lima H, Kato H, Sordillo EM, Convit J, Reyes-Jaimes O, Zerpa O, Paniz-Mondolfi AE.

Clin Exp Dermatol. 2014 Aug;39(6):708-12. doi: 10.1111/ced.12359. Epub 2014 Jul 1.

PMID:
24985142
4.

Interruption of Onchocerca volvulus transmission in Northern Venezuela.

Convit J, Schuler H, Borges R, Olivero V, Domínguez-Vázquez A, Frontado H, Grillet ME.

Parasit Vectors. 2013 Oct 7;6(1):289. doi: 10.1186/1756-3305-6-289.

5.
6.

Immunological correlates of cure in the first American cutaneous leishmaniasis patient treated by immunotherapy in Argentina. A case report.

García Bustos MF, Barrio AB, Parodi Ramoneda CM, Ramos F, Mora MC, Convit J, Basombrío MA.

Invest Clin. 2011 Dec;52(4):365-75.

PMID:
22523846
7.

Cojedes: a leprosy hyperendemic state.

Aranzazu N, Parra JJ, Cardenas M, Rada E, Zerpa O, Rivera T, Borges R, Gonzalez P, Morales J, Sosa R, Sanchez F, Convit J.

Int J Dermatol. 2012 Feb;51(2):186-94. doi: 10.1111/j.1365-4632.2011.05080.x.

PMID:
22250629
8.

Specific IgG antibody responses may be used to monitor leprosy treatment efficacy and as recurrence prognostic markers.

Duthie MS, Hay MN, Rada EM, Convit J, Ito L, Oyafuso LK, Manini MI, Goulart IM, Lobato J, Goulart LR, Carter D, Reed SG.

Eur J Clin Microbiol Infect Dis. 2011 Oct;30(10):1257-65. doi: 10.1007/s10096-011-1221-2. Epub 2011 May 5.

PMID:
21544695
9.

[Serological and cellular reactivity to mycobacterial proteins in Hansen's disease].

Rada E, Aranzazu N, Rodríguez V, Borges R, Convit J.

Invest Clin. 2010 Sep;51(3):325-40. Spanish.

PMID:
21305770
10.

[Immune response of Hansen's disease. Review].

Rada E, Aranzazu N, Convit J.

Invest Clin. 2009 Dec;50(4):513-27. Review. Spanish.

PMID:
20306725
11.

Familial and racial determinants of tumour suppressor genes promoter hypermethylation in breast tissues from healthy women.

Dumitrescu RG, Marian C, Krishnan SS, Spear SL, Kallakury BV, Perry DJ, Convit JR, Seillier-Moiseiwitsch F, Yang Y, Freudenheim JL, Shields PG.

J Cell Mol Med. 2010 Jun;14(6B):1468-75. doi: 10.1111/j.1582-4934.2009.00924.x. Epub 2009 Oct 3.

12.

Antibody response in children infected with Giardia intestinalis before and after treatment with Secnidazole.

Jiménez JC, Pinon A, Dive D, Capron M, Dei-Cas E, Convit J.

Am J Trop Med Hyg. 2009 Jan;80(1):11-5.

PMID:
19141831
13.

The effect of Bacille Calmette-Guérin vaccine on tuberculin reactivity in indigenous children from communities with high prevalence of tuberculosis.

Araujo Z, de Waard JH, de Larrea CF, Borges R, Convit J.

Vaccine. 2008 Oct 16;26(44):5575-81. doi: 10.1016/j.vaccine.2008.08.006. Epub 2008 Aug 22.

PMID:
18723065
14.

Diffuse cutaneous leishmaniasis responds to miltefosine but then relapses.

Zerpa O, Ulrich M, Blanco B, Polegre M, Avila A, Matos N, Mendoza I, Pratlong F, Ravel C, Convit J.

Br J Dermatol. 2007 Jun;156(6):1328-35. Epub 2007 Apr 17.

PMID:
17441955
15.

Serologic recognition of low molecular weight mycobacterial protein fractions in lepromatous patients with type II reactions (ENL).

Rada EM, Zambrano EA, Aranzazu N, Convit J.

Int J Lepr Other Mycobact Dis. 2005 Sep;73(3):222-5. No abstract available.

PMID:
16830648
16.

Treatment of diffuse cutaneous leishmaniasis with miltefosine: a case report.

Zerpa O, Blanco B, Kannee C, Ulrich M, Sindermann H, Engel J, Convit J.

Int J Dermatol. 2006 Jun;45(6):751-3.

PMID:
16796642
17.

Inorganic particles in the skin of inhabitants of volcanic areas of Central America: their possible immunomodulatory influence in leishmaniasis and leprosy.

Convit J, Ulrich M, Castillo J, De Lima H, Pérez M, Caballero N, Hung J, Arana B, Pérez P.

Trans R Soc Trop Med Hyg. 2006 Aug;100(8):734-9. Epub 2006 Jan 10.

PMID:
16406036
18.

[Some immunological aspects in the reaccional states of Hansen disease].

Rada E, Nacarid A, Convit J.

Invest Clin. 2005 Dec;46(4):381-9. Review. Spanish.

PMID:
16353545
19.

Hematologic values among Warao indians with tuberculosis from the Orinoco Delta of Venezuela.

Araujo Z, Fernández de Larrea C, López D, Fandiño C, Chirinos M, Convit J, Debora I, de Waard J.

Acta Cient Venez. 2003;54(4):247-53.

PMID:
15916179
20.

On the origin of leprosy.

Monot M, Honoré N, Garnier T, Araoz R, Coppée JY, Lacroix C, Sow S, Spencer JS, Truman RW, Williams DL, Gelber R, Virmond M, Flageul B, Cho SN, Ji B, Paniz-Mondolfi A, Convit J, Young S, Fine PE, Rasolofo V, Brennan PJ, Cole ST.

Science. 2005 May 13;308(5724):1040-2.

21.

Atypical cutaneous leishmaniasis in Central America: possible interaction between infectious and environmental elements.

Convit J, Ulrich M, Pérez M, Hung J, Castillo J, Rojas H, Viquez A, Araya LN, Lima HD.

Trans R Soc Trop Med Hyg. 2005 Jan;99(1):13-7.

PMID:
15550256
22.

Study of the antibody response against Mycobacterium tuberculosis antigens in Warao Amerindian children in Venezuela.

Araujo Z, Waard JH, Fernández de Larrea C, López D, Fandiño C, Maldonado A, Hernández E, Ocaña Y, Ortega R, Singh M, Ottenhoff TH, Arend SM, Convit J.

Mem Inst Oswaldo Cruz. 2004 Aug;99(5):517-24. Epub 2004 Nov 3.

23.

Immunotherapy of american cutaneous leishmaniasis in Venezuela during the period 1990-99.

Convit J, Ulrich M, Zerpa O, Borges R, Aranzazu N, Valera M, Villarroel H, Zapata Z, Tomedes I.

Trans R Soc Trop Med Hyg. 2003 Jul-Aug;97(4):469-72.

PMID:
15259484
24.

Organ-specific immunity in canine visceral leishmaniasis: analysis of symptomatic and asymptomatic dogs naturally infected with Leishmania chagasi.

Sanchez MA, Diaz NL, Zerpa O, Negron E, Convit J, Tapia FJ.

Am J Trop Med Hyg. 2004 Jun;70(6):618-24.

PMID:
15211002
25.
26.

[Study of immune response in Warao children from communities with high tuberculosis prevalence].

González N, De Cubeddu L, de Waard JH, Fandiño C, Fernández de Larrea C, López D, Maldonado A, Ocaña Y, Hernández E, Ortega R, Convit J, Pujol FH, Castés M, Araujo Z.

Invest Clin. 2003 Dec;44(4):303-18. Spanish.

PMID:
14727384
27.

Prevalence of Helicobacter pylori infection in Warao lineage communities of Delta Amacuro State, Venezuela.

Ortiz D, Cavazza ME, Rodríguez O, Hagel I, Correnti M, Convit J.

Mem Inst Oswaldo Cruz. 2003 Sep;98(6):721-5. Epub 2003 Oct 29.

28.
29.

Epidemiological aspects of human and canine visceral leishmaniasis in Venezuela.

Zerpa O, Ulrich M, Borges R, Rodríguez V, Centeno M, Negrón E, Belizario D, Convit J.

Rev Panam Salud Publica. 2003 Apr;13(4):239-45.

PMID:
12804153
30.

Gelatinase activity in Mycobacterium bovis protein extract.

Rada E, Zambrano EA, Rodríguez IY, Santaella C, Convit J.

Int J Lepr Other Mycobact Dis. 2002 Dec;70(4):260-8.

PMID:
12768927
31.

Epidemiological and immunological aspects of human visceral leishmaniasis on Margarita Island, Venezuela.

Zerpa O, Ulrich M, Benitez M, Avila C, Rodríguez V, Centeno M, Belizario D, Reed SG, Convit J.

Mem Inst Oswaldo Cruz. 2002 Dec;97(8):1079-83. Epub 2003 Jan 20.

32.

Fighting leprosy and other endemic diseases.

Convit J.

Rev Panam Salud Publica. 2002 Jul;12(1):1-4.

PMID:
12202018
33.

Molecular epidemiology of cutaneous leishmaniasis in Venezuela.

Rodriguez N, De Lima H, Aguilar CM, Rodriguez A, Barker DC, Convit J.

Trans R Soc Trop Med Hyg. 2002 Apr;96 Suppl 1:S105-9.

PMID:
12055822
34.

Cotton rats (Sigmodon hispidus) and black rats (Rattus rattus) as possible reservoirs of Leishmania spp. in Lara State, Venezuela.

De Lima H, De Guglielmo Z, Rodríguez A, Convit J, Rodriguez N.

Mem Inst Oswaldo Cruz. 2002 Mar;97(2):169-74.

35.

Intermediate or chronic cutaneous leishmaniasis: leukocyte immunophenotypes and cytokine characterisation of the lesion.

Diaz NL, Zerpa O, Ponce LV, Convit J, Rondon AJ, Tapia FJ.

Exp Dermatol. 2002 Feb;11(1):34-41.

PMID:
11952826
36.

[Tuberculosis in subjects under 15 years of age in the population of Warao in Venezuela].

Fernández de Larrea C, Fandiño C, López D, del Nogal B, Rodríguez N, Convit J, Araujo Z, de Waard JH.

Invest Clin. 2002 Mar;43(1):35-48. Spanish.

PMID:
11921746
37.

The molecular epidemiology of tuberculosis in Caracas, Venezuela, with IS6110 DNA fingerprinting.

Toro S, Armengol R, Convit J, de Salas AV, Takiff H, de Waard JH.

Acta Cient Venez. 2001;52 Suppl 1:33-5.

PMID:
11899702
38.
39.

Canine visceral leishmaniasis on Margarita Island (Nueva Esparta, Venezuela).

Zerpa O, Ulrich M, Negrón E, Rodríguez N, Centeno M, Rodríguez V, Barrios RM, Belizario D, Reed S, Convit J.

Trans R Soc Trop Med Hyg. 2000 Sep-Oct;94(5):484-7.

PMID:
11132371
40.

Immunotherapy and immunoprophylaxis of leprosy.

Convit J, Ulrich M.

Indian J Lepr. 2000 Jan-Mar;72(1):21-32. Review. No abstract available.

PMID:
10935184
41.

Serologic response to mycobacterial proteins in hansen's patients during multidrug treatment.

Rada E, Aranzazu N, Ulrich M, Convit J.

Int J Lepr Other Mycobact Dis. 1999 Dec;67(4):414-21.

PMID:
10700916
42.

Immunotherapy with live BCG plus heat killed Leishmania induces a T helper 1-like response in American cutaneous leishmaniasis patients.

Cabrera M, Blackwell JM, Castes M, Trujillo D, Convit J, Shaw MA.

Parasite Immunol. 2000 Feb;22(2):73-9.

43.

Detection of antibodies toward secreted mycobacterial antigen 85 in untreated leprosy patients' sera.

Rada-Schlaefli E, Santaella C, Aranzazu N, Convit J.

Int J Lepr Other Mycobact Dis. 1999 Jun;67(2):168-70. No abstract available.

PMID:
10472373
44.

Immunological reactions to mycobacterial proteins in the spectrum of leprosy.

Rada EM, Aranzazu N, Convit J.

Int J Lepr Other Mycobact Dis. 1997 Dec;65(4):497-500. No abstract available.

PMID:
9465162
45.

A follow-up study of multibacillary Hansen's disease patients treated with multidrug therapy (MDT) or MDT + immunotherapy (IMT).

Rada E, Ulrich M, Aranzazu N, Rodriguez V, Centeno M, Gonzalez I, Santaella C, Rodriguez M, Convit J.

Int J Lepr Other Mycobact Dis. 1997 Sep;65(3):320-7.

PMID:
9401484
46.

Ethics of HIV trials.

Aaby P, Babiker A, Darbyshire J, Nunn A, Barreto S, Alonso P, Badaro R, Barros F, Victoria C, Binka F, Biryahwaho B, Byabamazima C, Sempala S, Tugume B, Kalebu P, Kengeya-Kayondo J, Whitworth J, Paxton L, Convit J, Corrah T, McAdam K, Datta M, Dowlati Y, Fine P, Tanner M, et al.

Lancet. 1997 Nov 22;350(9090):1546. No abstract available.

PMID:
9388413
47.

Leishmaniasis: Immunological and clinical aspects and vaccines in Venezuela.

Convit J.

Clin Dermatol. 1996 Sep-Oct;14(5):479-87. Review. No abstract available.

PMID:
8889325
48.

Regarding analysis of vaccines.

Convit J.

Int J Lepr Other Mycobact Dis. 1995 Dec;63(4):576-7. No abstract available.

PMID:
8642226
49.

Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis.

Cabrera M, Shaw MA, Sharples C, Williams H, Castes M, Convit J, Blackwell JM.

J Exp Med. 1995 Nov 1;182(5):1259-64.

Supplemental Content

Loading ...
Support Center